Primary biliary cirrhosis and coronary atherosclerosis: Protective antioxidant effect of bilirubin

Bulletin of Experimental Biology and Medicine

Volumn 145, Issue 1, 2008, Pages 18-22

  Dudnik, L B ^a,b   Azyzova, O A ^a,b   Solovyova, N P ^a,b   Savchenkova, A P ^a,b   Pokrovskaya, M A ^a,b  

^a Federal Agency for Health Care and Social Development   (Russian Federation)

^b EMANUEL INSTITUTE OF BIOCHEMICAL PHYSICS   (Russian Federation)

Author keywords

Antioxidants; Atherosclerosis; Bilirubin; Lipid peroxidation; Primary biliary cirrhosis

Indexed keywords

ALKADIENE; BILIRUBIN; CATECHIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PHOSPHOLIPID; SILYMARIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; HYPERBILIRUBINEMIA; HYPOTHESIS; INHIBITION KINETICS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; RISK ASSESSMENT;

ADULT; AGED; ANTIOXIDANTS; BILIRUBIN; CORONARY ARTERY DISEASE; HUMANS; LIPID PEROXIDATION; LIVER CIRRHOSIS, BILIARY; MALONDIALDEHYDE; MIDDLE AGED;

EID: 50149109028     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0019-4     Document Type: Article

References (15)

1. A. F. Blyuger, L. B. Dudnik, A. Ya. Maiore, and I. E. Mieze, Byull. Eksp. Biol. Med., 99, No. 2, 166-169 (1985).
2. Yu. A. Vladimirov, O. A. Azyzova, A. I. Deev, et al., Free Radicals in Living Systems. Results of Science and Technology [in Russian], Moscow (1999), Vol. 29.
3. A. Aboutwerat, P. W. Pemberton, A. Smith, et al., Biochim. Biophys. Acta, 1637, No. 2, 142-150 (2003).
4. M. Alocca, A. Crosignani, A. Gritti, et al., Gut, 55, No. 12, 1795-1800 (2006).
5. P. Angulo, T. Patel, R. A. Jorgensen, et al., Hepatology, 32, No. 5, 897-900 (2000).
6. Ye. B. Burlakova, N. P. Pal'mina, and Ye. L. Mal'tseva, Membrane Lipid Oxidation, 3, 208-233 (1992).
7. F. Farinati, R. Cardin, N. de Maria, et al., Biol. Trace Elem. Res., 47, Nos. 1-3, 193-199 (1995).
8. W. L. Gregory, F. L. Game, M. Farrer, et al., Atherosclerosis, 105, No. 1, 43-50 (1994).
9. M. Madhavan, W. A. Wattigney, S. R. Srinivasan, and G. S. Berenson, Ibid., 131, No. 1, 107-113 (1997).
10. J. Neuzil, C. Weber, and A. Kontush, Ibid., 157, No. 2, 257-283 (2001).
11. G. Notas, N. Miliaraki, M. Kampa, et al., World J. Gastroenterol., 11, No. 27, 4194-4198 (2005).
12. M. J. O'Kane, P. L. Lynch, M. E. Callender, and E. R. Trimble, Atherosclerosis, 131, No. 2, 203-210 (1997).
13. H. A. Schwertner and J. R. Jr. Fischer, Ibid., 150, No. 2, 381-387 (2000). 381-387 (2000).
14. H. A. Schwertner, W. G. Jackson, and G. Tolan, Clin. Chem., 40, No. 1, 18-23 (1994).
15. S. K. Wattanapitayakul and J. A. Bauer, Pharmacol. Ther., 89, No. 2, 187-206 (2001).